These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells. Ly D, Mi QS, Hussain S, Delovitch TL. J Immunol; 2006 Sep 15; 177(6):3695-704. PubMed ID: 16951329 [Abstract] [Full Text] [Related]
12. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells. Mukherjee R, Chaturvedi P, Qin HY, Singh B. J Autoimmun; 2003 Nov 01; 21(3):221-37. PubMed ID: 14599847 [Abstract] [Full Text] [Related]
17. TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H, Strober W. J Immunol; 2004 Jan 15; 172(2):834-42. PubMed ID: 14707053 [Abstract] [Full Text] [Related]
18. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse. Herbelin A, Gombert JM, Lepault F, Bach JF, Chatenoud L. J Immunol; 1998 Sep 01; 161(5):2620-8. PubMed ID: 9725264 [Abstract] [Full Text] [Related]
19. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma. Trembleau S, Penna G, Gregori S, Giarratana N, Adorini L. J Immunol; 2003 Jun 01; 170(11):5491-501. PubMed ID: 12759426 [Abstract] [Full Text] [Related]